Apexbio
Lab Reagents
Apexbio Laboratories manufactures the apexbio reagents distributed by Genprice. The Apexbio reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Apexbio. Other Apexbio products are available in stock. Specificity: Apexbio Category:
GF 109203X |
|||
| A8342-S | ApexBio | Evaluation Sample | EUR 97.2 |
|
Description: GF 109203X is a potent and selective inhibitor of protein kinase C [1]. |
|||
Go 6983 |
|||
| A8343-10 | ApexBio | 10 mg | EUR 247.2 |
|
Description: Go 6983 is a selective inhibitor of PKC?, PKC?, PKC?, PKC? and PKC? with IC50 value of 7 nM, 7 nM, 6 nM, 10 nM, and 20 mM, respectively [1]. |
|||
Go 6983 |
|||
| A8343-5 | ApexBio | 5 mg | EUR 177.6 |
|
Description: Go 6983 is a selective inhibitor of PKC?, PKC?, PKC?, PKC? and PKC? with IC50 value of 7 nM, 7 nM, 6 nM, 10 nM, and 20 mM, respectively [1]. |
|||
Go 6983 |
|||
| A8343-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 199.2 |
|
Description: Go 6983 is a selective inhibitor of PKC?, PKC?, PKC?, PKC? and PKC? with IC50 value of 7 nM, 7 nM, 6 nM, 10 nM, and 20 mM, respectively [1]. |
|||
K-252c |
|||
| A8344-1 | ApexBio | 1 mg | EUR 204 |
|
Description: K-252c is a cell-permeable, reversible, and ATP-competitive inhibitor of protein kinase C (PKC) and protein kinase A (PKA) with IC50 value of 2.45 ?M and 25.7 ?M, respectively. |
|||
K-252c |
|||
| A8344-25 | ApexBio | 25 mg | EUR 1452 |
|
Description: K-252c is a cell-permeable, reversible, and ATP-competitive inhibitor of protein kinase C (PKC) and protein kinase A (PKA) with IC50 value of 2.45 ?M and 25.7 ?M, respectively. |
|||
K-252c |
|||
| A8344-5 | ApexBio | 5 mg | EUR 616.8 |
|
Description: K-252c is a cell-permeable, reversible, and ATP-competitive inhibitor of protein kinase C (PKC) and protein kinase A (PKA) with IC50 value of 2.45 ?M and 25.7 ?M, respectively. |
|||
K-252c |
|||
| A8344-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 518.4 |
|
Description: K-252c is a cell-permeable, reversible, and ATP-competitive inhibitor of protein kinase C (PKC) and protein kinase A (PKA) with IC50 value of 2.45 ?M and 25.7 ?M, respectively. |
|||
PF-562271 HCl |
|||
| A8345-10 | ApexBio | 10 mg | EUR 324 |
|
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity. |
|||
PF-562271 HCl |
|||
| A8345-5 | ApexBio | 5 mg | EUR 226.8 |
|
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity. |
|||
PF-562271 HCl |
|||
| A8345-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 393.6 |
|
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity. |
|||
PF-562271 HCl |
|||
| A8345-50 | ApexBio | 50 mg | EUR 714 |
|
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity. |
|||
PF-562271 HCl |
|||
| A8345-S | ApexBio | Evaluation Sample | EUR 97.2 |
|
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity. |
|||
BYL-719 |
|||
| A8346-100 | ApexBio | 100 mg | EUR 1039.2 |
|
Description: BYL719 is a selective PI3K? inhibitor with IC50 of 5 nM. It has minimal effect on PI3K?, ? and ?[1]. Dysregulation of the PI3K signaling pathway is involved in multiple cancers. |
|||
BYL-719 |
|||
| A8346-20 | ApexBio | 20 mg | EUR 338.4 |
|
Description: BYL719 is a selective PI3K? inhibitor with IC50 of 5 nM. It has minimal effect on PI3K?, ? and ?[1]. Dysregulation of the PI3K signaling pathway is involved in multiple cancers. |
|||
BYL-719 |
|||
| A8346-5 | ApexBio | 5 mg | EUR 184.8 |
|
Description: BYL719 is a selective PI3K? inhibitor with IC50 of 5 nM. It has minimal effect on PI3K?, ? and ?[1]. Dysregulation of the PI3K signaling pathway is involved in multiple cancers. |
|||
BYL-719 |
|||
| A8346-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 199.2 |
|
Description: BYL719 is a selective PI3K? inhibitor with IC50 of 5 nM. It has minimal effect on PI3K?, ? and ?[1]. Dysregulation of the PI3K signaling pathway is involved in multiple cancers. |
|||
